Interaction of mesenchymal stem cells with fibroblast-like synoviocytes via cadherin-11 promotes angiogenesis by enhanced secretion of placental growth factor

Journal of Immunology

Volumn 192, Issue 7, 2014, Pages 3003-3010

  Park, Su Jung ^a   Kim, Ki Jo ^b   Kim, Wan Uk ^a,b   Cho, Chul Soo ^a,c  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CADHERIN; CADHERIN 11; PLACENTAL GROWTH FACTOR; PROTEIN KINASE B; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; ARTICLE; CELL INTERACTION; CELL MIGRATION; CHEMOTAXIS ASSAY; COCULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; SYNOVIOCYTE;

ANIMALS; ARTHRITIS, RHEUMATOID; BLOTTING, WESTERN; CADHERINS; CELL COMMUNICATION; CELLS, CULTURED; CHEMOTAXIS; COCULTURE TECHNIQUES; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FIBROBLASTS; HUMANS; LAMININ; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PREGNANCY PROTEINS; PROTEOGLYCANS; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SYNOVIAL MEMBRANE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84897543140     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302177     Document Type: Article

References (50)

1. Harris, E. D., Jr. 1990. Rheumatoid arthritis. Pathophysiology and implications for therapy. N. Engl. J. Med. 322: 1277-1289.
2. Koch, A. E. 1998. Review: angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum. 41: 951-962.
3. Jackson, J. R., M. P. Seed, C. H. Kircher, D. A. Willoughby, and J. D. Winkler. 1997. The codependence of angiogenesis and chronic inflammation. FASEB J. 11: 457-465.
4. Maglione, D., V. Guerriero, G. Viglietto, P. Delli-Bovi, and M. G. Persico. 1991. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc. Natl. Acad. Sci. USA 88: 9267-9271.
5. Yoo, S. A., H. J. Yoon, H. S. Kim, C. B. Chae, S. De Falco, C. S. Cho, and W. U. Kim. 2009. Role of placenta growth factor and its receptor flt-1 in rheumatoid inflammation: a link between angiogenesis and inflammation. Arthritis Rheum. 60: 345-354.
6. DiSalvo, J., M. L. Bayne, G. Conn, P. W. Kwok, P. G. Trivedi, D. D. Soderman, T. M. Palisi, K. A. Sullivan, and K. A. Thomas. 1995. Purification and characterization of a naturally occurring vascular endothelial growth factor.placenta growth factor heterodimer. J. Biol. Chem. 270: 7717-7723.
7. Selvaraj, S. K., R. K. Giri, N. Perelman, C. Johnson, P. Malik, and V. K. Kalra. 2003. Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor. Blood 102: 1515-1524.
8. Pittenger, M. F., A. M. Mackay, S. C. Beck, R. K. Jaiswal, R. Douglas, J. D. Mosca, M. A. Moorman, D. W. Simonetti, S. Craig, and D. R. Marshak. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
9. Chamberlain, G., J. Fox, B. Ashton, and J. Middleton. 2007. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25: 2739-2749.
10. De Miguel, M. P., S. Fuentes-Julián, A. Blázquez- Martínez, C. Y. Pascual, M. A. Aller, J. Arias, and F. Arnalich-Montiel. 2012. Immunosuppressive properties of mesenchymal stem cells: advances and applications. Curr. Mol. Med. 12: 574-591.
11. Kuhn, N. Z., and R. S. Tuan. 2010. Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis. J. Cell. Physiol. 222: 268-277.
12. De Bari, C., F. Dell'Accio, P. Tylzanowski, and F. P. Luyten. 2001. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum. 44: 1928-1942.
13. Jones, E. A., A. English, K. Henshaw, S. E. Kinsey, A. F. Markham, P. Emery, and D. McGonagle. 2004. Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis. Arthritis Rheum. 50: 817-827.
14. Marinova-Mutafchieva, L., R. O. Williams, K. Funa, R. N. Maini, and N. J. Zvaifler. 2002. Inflammation is preceded by tumor necrosis factor-dependent infiltration of mesenchymal cells in experimental arthritis. Arthritis Rheum. 46:507-513.
15. Djouad, F., V. Fritz, F. Apparailly, P. Louis-Plence, C. Bony, J. Sany, C. Jorgensen, and D. Noël. 2005. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum. 52: 1595-1603.
16. Li, X., and S. S. Makarov. 2006. An essential role of NF-kappaB in the "tumorlike" phenotype of arthritic synoviocytes. Proc. Natl. Acad. Sci. USA 103:17432-17437.
17. Miao, Z., J. Jin, L. Chen, J. Zhu, W. Huang, J. Zhao, H. Qian, and X. Zhang. 2006. Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Cell Biol. Int. 30: 681-687.
18. Waris, V., T. Sillat, E. Waris, L. Virkki, J. Mandelin, M. Takagi, and Y. T. Konttinen. 2012. Role and regulation of VEGF and its receptors 1 and 2 in the aseptic loosening of total hip implants. J. Orthop. Res. 30: 1830-1836.
19. Li, B., C. Wang, Y. Zhang, X. Y. Zhao, B. Huang, P. F. Wu, Q. Li, H. Li, Y. S. Liu, L. Y. Cao, et al. 2013. Elevated PLGF contributes to small-cell lung cancer brain metastasis. Oncogene 32: 2952-2962.
20. Cho, C. S., M. L. Cho, S. Y. Min, W. U. Kim, D. J. Min, S. S. Lee, S. H. Park, J. Choe, and H. Y. Kim. 2000. CD40 engagement on synovial fibroblast upregulates production of vascular endothelial growth factor. J. Immunol. 164: 5055-5061.
21. Kong, J. S., S. A. Yoo, J. W. Kim, S. P. Yang, C. B. Chae, V. Tarallo, S. De Falco, S. H. Ryu, C. S. Cho, and W. U. Kim. 2010. Anti-neuropilin-1 peptide inhibition of synoviocyte survival, angiogenesis, and experimental arthritis. Arthritis Rheum. 62: 179-190.
22. Bae, D. G., T. D. Kim, G. Li, W. H. Yoon, and C. B. Chae. 2005. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis. Clin. Cancer Res. 11: 2651-2661.
23. Park, J. E., H. H. Chen, J. Winer, K. A. Houck, and N. Ferrara. 1994. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J. Biol. Chem. 269: 25646-25654.
24. Tchaikovski, V., G. Fellbrich, and J. Waltenberger. 2008. The molecular basis of VEGFR-1 signal transduction pathways in primary human monocytes. Arterioscler. Thromb. Vasc. Biol. 28: 322-328.
25. Brenchley, P. E. C. 1999. Angiogenesis in inflammatory joint disease: a target for therapeutic intervention. Clin. Exp. Immunol. 121: 426-429.
26. Paleolog, E. M., S. Young, A. C. Stark, R. V. McCloskey, M. Feldmann, and R. N. Maini. 1998. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor a and interleukin-1 in rheumatoid arthritis. Arthritis Rheum. 41: 1258-1265.
27. Agarwal, S. K., and M. B. Brenner. 2006. Role of adhesion molecules in synovial inflammation. Curr. Opin. Rheumatol. 18: 268-276.
28. Majumdar, M. K., M. Keane-Moore, D. Buyaner, W. B. Hardy, M. A. Moorman, K. R. McIntosh, and J. D. Mosca. 2003. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J. Biomed. Sci. 10: 228-241.
29. Wheelock, M. J., and K. R. Johnson. 2003. Cadherins as modulators of cellular phenotype. Annu. Rev. Cell Dev. Biol. 19: 207-235.
30. Simonneau, L., M. Kitagawa, S. Suzuki, and J. P. Thiery. 1995. Cadherin 11 expression marks the mesenchymal phenotype: towards new functions for cadherins? Cell Adhes. Commun. 3: 115-130.
31. Orlandini, M., and S. Oliviero. 2001. In fibroblasts Vegf-D expression is induced by cell-cell contact mediated by cadherin-11. J. Biol. Chem. 276: 6576-6581.
32. Corr, M., and N. J. Zvaifler. 2002. Mesenchymal precursor cells. Ann. Rheum. Dis. 61: 3-5.
33. Ishida, A., J. Murray, Y. Saito, C. Kanthou, O. Benzakour, M. Shibuya, and E. S. Wijelath. 2001. Expression of vascular endothelial growth factor receptors in smooth muscle cells. J. Cell. Physiol. 188: 359-368.
34. Barleon, B., S. Sozzani, D. Zhou, H. A. Weich, A. Mantovani, and D. Marmé. 1996. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87: 3336-3343.
35. Gerber, H. P., T. H. Vu, A. M. Ryan, J. Kowalski, Z. Werb, and N. Ferrara. 1999. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med. 5: 623-628.
36. Mayer, H., H. Bertram, W. Lindenmaier, T. Korff, H. Weber, and H. Weich. 2005. Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation. J. Cell. Biochem. 95: 827-839.
37. Luttun, A., M. Tjwa, L. Moons, Y. Wu, A. Angelillo-Scherrer, F. Liao, J. A. Nagy, A. Hooper, J. Priller, B. De Klerck, et al. 2002. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat. Med. 8: 831-840.
38. Taylor, A. P., E. Leon, and D. M. Goldenberg. 2010. Placental growth factor (PlGF) enhances breast cancer cell motility by mobilising ERK1/2 phosphorylation and cytoskeletal rearrangement. Br. J. Cancer 103: 82-89.
39. Desai, J., V. Holt-Shore, R. J. Torry, M. R. Caudle, and D. S. Torry. 1999. Signal transduction and biological function of placenta growth factor in primary human trophoblast. Biol. Reprod. 60: 887-892.
40. Fu, X., B. Han, S. Cai, Y. Lei, T. Sun, and Z. Sheng. 2009. Migration of bone marrow-derived mesenchymal stem cells induced by tumor necrosis factoralpha and its possible role in wound healing. Wound Repair Regen. 17: 185-191.
41. Ryu, C. H., S. A. Park, S. M. Kim, J. Y. Lim, C. H. Jeong, J. A. Jun, J. H. Oh, S. H. Park, W. I. Oh, and S. S. Jeun. 2010. Migration of human umbilical cord blood mesenchymal stem cells mediated by stromal cell-derived factor-1/CXCR4 axis via Akt, ERK, and p38 signal transduction pathways. Biochem. Biophys. Res. Commun. 398: 105-110.
42. Yang, K., X. Q. Wang, Y. S. He, L. Lu, Q. J. Chen, J. Liu, and W. F. Shen. 2010. Advanced glycation end products induce chemokine/cytokine production via activation of p38 pathway and inhibit proliferation and migration of bone marrow mesenchymal stem cells. Cardiovasc. Diabetol. 9: 66.
43. Xue, G., and B. A. Hemmings. 2013. PKB/Akt-dependent regulation of cell motility. J. Natl. Cancer Inst. 105: 393-404.
44. Li, L., Y. Xia, Z. Wang, X. Cao, Z. Da, G. Guo, J. Qian, X. Liu, Y. Fan, L. Sun, et al. 2011. Suppression of the PI3K-Akt pathway is involved in the decreased adhesion and migration of bone marrow-derived mesenchymal stem cells from non-obese diabetic mice. Cell Biol. Int. 35: 961-966.
45. Li, H. J., F. Reinhardt, H. R. Herschman, and R. A. Weinberg. 2012. Cancerstimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling. Cancer Discov. 2: 840-855.
46. Suzuki, K., R. Sun, M. Origuchi, M. Kanehira, T. Takahata, J. Itoh, A. Umezawa, H. Kijima, S. Fukuda, and Y. Saijo. 2011. Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization. Mol. Med. 17:579-587.
47. Okazaki, M., S. Takeshita, S. Kawai, R. Kikuno, A. Tsujimura, A. Kudo, and E. Amann. 1994. Molecular cloning and characterization of OB-cadherin, a new member of cadherin family expressed in osteoblasts. J. Biol. Chem. 269: 12092-12098.
48. Chang, S. K., E. H. Noss, M. Chen, Z. Gu, K. Townsend, R. Grenha, L. Leon, S. Y. Lee, D. M. Lee, and M. B. Brenner. 2011. Cadherin-11 regulates fibroblast inflammation. Proc. Natl. Acad. Sci. USA 108: 8402-8407.
49. Vandooren, B., T. Cantaert, M. ter Borg, T. Noordenbos, R. Kuhlman, D. Gerlag, T. Bongartz, K. Reedquist, P. P. Tak, and D. Baeten. 2008. Tumor necrosis factor alpha drives cadherin 11 expression in rheumatoid inflammation. Arthritis Rheum. 58: 3051-3062.
50. Marinova-Mutafchieva, L., P. Taylor, K. Funa, R. N. Maini, and N. J. Zvaifler. 2000. Mesenchymal cells expressing bone morphogenetic protein receptors are present in the rheumatoid arthritis joint. Arthritis Rheum. 43: 2046-2055.